SynthesisInternational journal of clinical oncology2025
Association between increased proteinuria induced by Bevacizumab, Ramucirumab, and Aflibercept and the risk of renal impairment and failure: a systematic review and meta-analysis.
Yuma Shibutani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.